STOCK TITAN

Horizon Space II (HSPT) extends merger timeline as over 6.7M shares redeemed

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Horizon Space Acquisition II Corp. entered into a $50,000 unsecured promissory note with William Wang to fund an extension fee, allowing one additional month to complete its initial business combination, moving the deadline from February 18, 2026 to March 18, 2026.

The note bears no interest, is due at business combination or company expiry, and may be converted into private units at $10.00 per unit. Shareholders approved the SPAC’s business combination and extension proposals, and 2,012,378 public shares were submitted for redemption in connection with the business combination, while 4,709,337 public shares were submitted for redemption in connection with the extension.

Positive

  • None.

Negative

  • None.

Insights

Horizon Space II buys time with a small, insider-linked bridge note and faces sizable share redemptions.

Horizon Space Acquisition II Corp. obtained a $50,000 interest-free promissory note from William Wang to fund the one-month extension fee and keep its business combination alive. The lender can convert the note into private units at $10.00 per unit, adding a modest potential equity overhang.

Shareholder approvals of the business combination and extension proposals clear key procedural hurdles. However, redemptions of 2,012,378 public shares tied to the business combination and 4,709,337 public shares tied to the extension significantly reduce the public float and likely the cash remaining in the trust. Subsequent company disclosures may clarify the post-redemption capital structure around the anticipated closing.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 18, 2026

 

HORIZON SPACE ACQUISITION II CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

 

001-42406

 

N/A

(State or other jurisdiction

 

(Commission 

 

(IRS Employer

of incorporation)

 

File Number) 

 

Identification Number)

 

1412 Broadway

21st Floor, Suite 21V

New York, NY 10018 

(Address of principal executive offices)

 

Tel: (646) 257-5537

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act.

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Units, consisting of one ordinary share, $0.0001 par value, and one Right to acquire one-tenth of one ordinary share

 

HSPTU

 

The Nasdaq Stock Market LLC

Ordinary shares, par value $0.0001 per share

 

HSPT

 

The Nasdaq Stock Market LLC

Rights, each whole right to acquire one-tenth of one ordinary share

 

HSPTR

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

  

Item 1.01. Entry into a Material Definitive Agreement.

 

The disclosures set forth under Item 2.03 are incorporated by reference.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

Pursuant to the amendment to the amended and restated memorandum and articles of association approved in the extraordinary general meeting held on February 13, 2026 (the “Charter Amendment”) of Horizon Space Acquisition II Corp., a Cayman Islands exempted company (the “Company”), the Company currently has until February 18, 2026 to complete its initial business combination. However, the Company may extend the period of time to consummate a business combination up to twelve times, each by an additional one-month extension, up to February 18, 2027, subject to Horizon Space Acquisition II Sponsor Corp., a Cayman Islands company, the sponsor of the Company (the “Sponsor”) and/or its designee, depositing the lesser of (i) $50,000 for all remaining public shares and (ii) $0.033 for each remaining public share (the “Extension Fee”) into the trust account of the Company (the “Trust Account”).

 

On or about February 18, 2026, an aggregate of $50,000 of the Extension Fee was deposited into the Trust Account for the Company’s public shareholders (the “Extension Payment”) by Mr. William Wang (the “Payee”), which enables the Company to extend the period of time it has to consummate its initial business combination by one month from February 18, 2026 to March18, 2026 (the “Extension”). The Extension is the first of the twelve Extensions permitted pursuant to the Charter Amendment. Mr. William Wang is the Chief Executive Officer of SL BIO Ltd., a Cayman Islands exempted company limited by shares (“SL Bio”). On May 9, 2025, the Company, SL Bio, SL Science Holding Limited, a Cayman Islands exempted company limited by shares (“PubCo”), CW Mega Limited, a Cayman Islands exempted company limited by shares (“Merger Sub I”), and WW Century Limited, a Cayman Islands exempted company limited by shares (“Merger Sub II”), entered into a business combination agreement, pursuant to which, among other things, (i) Merger Sub I will merge with and into the Company, with the Company as the surviving entity and a wholly-owned subsidiary of PubCo (the “First Merger”), and (ii) following the First Merger, Merger Sub II will merge with and into SL Bio, with SL Bio as the surviving entity and a wholly-owned subsidiary of PubCo.

 

In connection with the Extension Payment, on February 18, 2026, the Company issued an unsecured promissory note of $50,000 (the “Note”) to the Payee.

 

The Note bears no interest and is payable in full upon the earlier to occur of (i) the consummation of the Company’s business combination or (ii) the date of expiry of the term of the Company (the “Maturity Date”). The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of the Company’s obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against the Company; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Note may be accelerated.

 

The Payee has the right, but not the obligation, to convert the Note, in whole or in part, respectively, into private units (the “Units”) of the Company, each consisting of one ordinary share, par value $0.0001 per share (the “Ordinary Share”), and one right to receive one-tenth (1/10) of one Ordinary Share upon the consummation of a business combination, as described in the prospectus of the Company (File No: 333-282758), by providing the Company with written notice of the intention to convert at least two business days prior to the closing of the business combination. The number of Units to be received by the Payee in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to the Payee by (y) $10.00.

 

The issuance of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

A copy of the Note is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. The foregoing description of the Note does not purport to be complete and is subject to, and is qualified in its entirety by, the full text of the Note.

 

 Item 3.02 Unregistered Sales of Equity Securities.

 

The information disclosed under Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02 to the extent required herein. The Units (and the underlying securities) issuable upon conversion of the Note, if any, (1) may not, subject to certain limited exceptions, be transferable or salable by the Payee until the completion of the Company’s initial business combination and (2) are entitled to registration rights.

 

Item 8.01. Other Events.

 

On February 12, 2026, the Company held an extraordinary general meeting, where the shareholders of the Company approved (i) the Business Combination Proposals (as defined in the definitive proxy statement filed by the Company (as amended and supplemented, the “Business Combination Proxy Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) on January 13, 2026), (ii) the Amended M&A Proposal (as defined in the Business Combination Proxy Statement), and (iii) the Sole Director Appointment Proposal (as defined in the Business Combination Proxy Statement).

 

According to the information provided by the Company’s transfer agent, VStock Transfer, LLC (“VStock”), in connection with the votes to approve the Business Combination Proposals, as of February 23, 2026, 2,012,378 public shares of the Company were rendered for redemption (the “Business Combination Redemption”).

  

On February 13, 2026, the Company held another extraordinary general meeting, where the shareholders of the Company approved (i) the MAA Amendment Proposal (as defined in the definitive proxy statement filed by the Company (as amended and supplemented, the “Extension Proxy Statement”) with the SEC on February 3, 2026), and (ii) the Trust Amendment Proposal (as defined in the Extension Proxy Statement).

  

According to the information provided by VStock, in connection with the votes to approve the MAA Amendment Proposal and the Trust Amendment Proposal, as of February 23, 2026, 4,709,337 public shares of the Company were rendered for redemption (the “Extension Redemption”), which do not include the public shares rendered for the Business Combination Redemption.

 

As a result of the Extension, the Company is working with the trust agent to execute the Extension Redemption. Any public shares rendered for the Business Combination Redemption will be redeemed upon and following the consummation of the Business Combination.

 

 

2

 

 

Item 9.01 Financial Statements and Exhibits. 

 

Exhibit No.

 

Description

10.1

 

Promissory Note, dated February 18, 2026, issued by the Company to William Wang

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

3

 

   

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Horizon Space Acquisition II Corp.

 

 

 

 

Date: February 24, 2026

By:

/s/ Mingyu (Michael) Li

 

 

Name: 

Mingyu (Michael) Li

 

 

Title:

Chief Executive Officer

 

  

 

4

 

FAQ

What did Horizon Space Acquisition II Corp. (HSPT) announce in this 8-K?

Horizon Space II disclosed a one-month extension of its business combination deadline to March 18, 2026, funded by a $50,000 promissory note. It also reported shareholder approvals of combination and extension proposals, plus substantial public share redemptions tied to both votes.

How is the Horizon Space II (HSPT) business combination deadline being extended?

The deadline is extended via a $50,000 “Extension Fee” deposited into the trust account on February 18, 2026. This payment, funded by a promissory note from William Wang, moves the business combination deadline from February 18, 2026 to March 18, 2026.

What are the key terms of the $50,000 promissory note to Horizon Space II?

The unsecured note for $50,000 bears no interest and is payable at business combination closing or company expiry. William Wang can convert the outstanding principal into private units at $10.00 per unit, each unit including one ordinary share and a right to one-tenth of a share.

How many Horizon Space II public shares were redeemed around the business combination vote?

According to transfer agent data, 2,012,378 public shares were submitted for redemption related to the business combination proposals. These shares are expected to be redeemed upon and following consummation of the business combination, reducing the public float and trust-held shares.

What redemptions occurred in connection with the Horizon Space II extension proposals?

In connection with the MAA Amendment and Trust Amendment proposals, 4,709,337 public shares were rendered for redemption. These shares are separate from those tied to the business combination redemption and are being processed with the trust agent following approval of the extension.

Can the Horizon Space II extension note convert into equity, and what are the restrictions?

Yes. William Wang may convert the note into private units at $10.00 per unit before the business combination closing. These units, and their underlying securities, generally cannot be transferred until completion of the business combination, and they benefit from registration rights.

Filing Exhibits & Attachments

6 documents
Horizon Space Acquisition II Corp

NASDAQ:HSPT

View HSPT Stock Overview

HSPT Rankings

HSPT Latest News

HSPT Latest SEC Filings

HSPT Stock Data

61.63M
7.36M
Shell Companies
Blank Checks
United States
NEW YORK